MPO and cystic fibrosis: MPO polymorphism, whose variant allele is not related to susceptibility but to protection, presented 0.30 (48.5% heterozygous and 9.1% homozygous) in NCF, and 0.31 (50% heterozygous and 6.5% homozygous) in CF group.